FDA Approves CEFAZOLIN — WG Critical Care, LLC

# FDA Approves WG Critical Care's Intravenous Cefazolin Formulation WG Critical Care, LLC received FDA approval for its intravenous cefazolin sodium injection (NDA211413), a broad-spectrum antibiotic used primarily in surgical prophylaxis and acute bacterial infections. The approval expands the competitive landscape for this essential first-generation cephalosporin, potentially intensifying pricing pressure in the generic injectable antibiotic market while addressing supply chain demands in hospital and critical care settings.